Phase II study of vinorelbine in patients with androgen-independent prostate cancer.

Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D

Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D.

Affiliation

Oudard S; Department of Oncology, Hjpital Européen Georges Pompidou, Paris, France. stephane.oudard@hop.egp.ap-hop-paris.fr

Ann Oncol ; 12(6): 847-52, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11484963

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Vinblastine / Adenocarcinoma / Androgens / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials Aspects: Patient_preference Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links